Autologous Tumor Lysate-pulsed Dendritic Cell Immunotherapy for Pediatric Patients with Newly Diagnosed or Recurrent High-grade Gliomas

Immunotherapy has the potential to improve clinical outcomes with little toxicity for pediatric patients with brain tumors. We conducted a pilot feasibility study of tumor lysate-pulsed dendritic cell (DC) vaccination in pediatric patients (1 to 18 years old) with newly diagnosed or recurrent high-g...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lasky, Joseph L., Panosyan, Eduard H., Plant, Ashley, Davidson, Tom, Yong, William H., Prins, Robert M., Liau, Linda M., Moore, Theodore B.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4018463/
https://ncbi.nlm.nih.gov/pubmed/23645755
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky